pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,157 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
Gene Therapy for Bone Fracture
Bone Fracture
Cedars-Sinai Medical Center
0 catalysts
Preclinical
Gene Therapy for Branched-Chain 2-Ketoacid Dehydrogenase Deficiency
Maple Syrup Urine Disease
Clinic for Special Children
0 catalysts
Preclinical
Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2C/R5
Limb-Girdle Muscular Dystrophy
Evolyra Therapeutics
0 catalysts
Preclinical
← prev
page 16 of 39
next →
131
Pain89
Neurology1
Gene Therapy to Activate CD40LG for Genetic Disorders
University of California Los Angeles
0 catalysts
Preclinical
Gene Therapy to Activate FOXP3 for Immune Dysregulation Polyendocrinopathy X-linked (IPEX) Syndrome
ImmunoVec Inc
0 catalysts
Preclinical
Gene Therapy to Activate PCCA for Propionic Acidemia
Propionic Acidemia
National Institutes of Health
0 catalysts
Preclinical
Gene Therapy to Activate gp91phox for Chronic Granulomatous Disease
Chronic Granulomatous Disease
ImmunoVec Inc
0 catalysts
Preclinical
Gene Therapy to Target BCMA and CS1 for Multiple Myeloma
Multiple Myeloma (Kahler Disease)
University of California Los Angeles
0 catalysts
Preclinical
Genetically Engineered Native Bacteria
Familial Adenomatous Polyposis
Endure Biotherapeutics
0 catalysts
Preclinical
Gliflozins
Congestive Heart Failure (Heart Failure)
$RTXRTX Corp
0 catalysts
Preclinical
Glucokinase Regulator
Hyperinsulinemia
Hua Medicine Shanghai Ltd
0 catalysts
Preclinical
Glunozumab
Unspecified
Lys Therapeutics SAS
0 catalysts
Preclinical
GlyTR1 Bi-specific Protein
Solid Tumor
GlyTR Therapeutics Inc
0 catalysts
Preclinical
Glycogen Storage Disease 1B
Glycogen Storage Disease (GSD)
$PRMEPrime Medicine, Inc.
0 catalysts
Preclinical
Glycolic acid + D-lactic acid
Amyotrophic Lateral Sclerosis
Neurevo GmbH
0 catalysts
Preclinical
Granulocyte Colony-Stimulating-Factor (G-CSF)
Thromboangiitis obliterans (Buerger disease)
Vasogenesis Inc
0 catalysts
Preclinical
Granzyme B Associated Peptide
Herpes Simplex Encephalitis
Biojenc LLC
0 catalysts
Preclinical
HBO-001
HysensBio Corp
0 catalysts
Preclinical
HFG-1
Diabetes
HighField Biopharmaceuticals, Inc.
0 catalysts
Preclinical
HIV Vaccine
Human Immunodeficiency Virus (HIV) Infections (AIDS)
DelSiTech Ltd
0 catalysts
Preclinical
HL-001
Idiopathic Pulmonary Fibrosis
UBE Corp
0 catalysts
Preclinical
HLH Therapy
Hemophagocytic Lymphohistiocytosis
GenexGen Inc
0 catalysts
Preclinical
HNC-1798
Parkinson's Disease
Guangzhou Henovcom Bioscience Co Ltd
0 catalysts
Preclinical
HNC-280
Hepatitis B
Guangzhou Henovcom Bioscience Co Ltd
0 catalysts
Preclinical
HND-034
Lung Cancer
Handa Pharmaceuticals LLC
0 catalysts
Preclinical
HND-039
Kidney Cancer (Renal Cell Cancer)
Handa Pharmaceuticals LLC
0 catalysts
Preclinical
HND-042
Unspecified Cancer
Handa Pharmaceuticals LLC
0 catalysts
Preclinical
HP-520
Hinova Pharmaceuticals Inc
0 catalysts
Preclinical
HT-ALZ
Alzheimer's Disease
$HOTHHoth Therapeutics, Inc.
0 catalysts
Preclinical
HT-KIT
Anaphylaxis
$HOTHHoth Therapeutics, Inc.
0 catalysts